Empaa-M Tablet 12.5/500

About Empaa-M Tablet 12.5/500

Empaa-M Tablet 12.5/500 Uses

• Type 2 diabetes mellitus in adults who need better blood sugar control
• Cases where metformin alone is not controlling blood glucose well enough
• Add-on therapy alongside a healthy diet and regular exercise
• Reducing the risk of major cardiovascular events in adults with type 2 diabetes and existing heart disease

Empaa-M Tablet 12.5/500 Benefits

• Lowers blood sugar through two separate mechanisms in one tablet
• May support modest weight loss compared to some other diabetes medicines
• Can lower blood pressure slightly in some patients
• Offers cardiovascular and kidney protection benefits linked to empagliflozin
• Simplifies treatment by combining two drugs into a single tablet, which improves adherence

What Experts Say

Endocrinologists often describe empagliflozin and metformin as a practical pairing because they lower blood sugar through different pathways. Metformin reduces glucose production in the liver, while empagliflozin helps the kidneys remove excess sugar through urine. Combining both in one tablet can improve treatment adherence, which specialists call one of the biggest challenges in long term diabetes care.

Diabetes specialists often note that empagliflozin offers benefits beyond blood sugar control. Clinical evidence links it to a reduced risk of heart failure hospitalization and slower progression of kidney disease in people with type 2 diabetes. This makes it a preferred option for patients who also have cardiovascular or kidney concerns.

Experts also caution that this combination is not suitable for everyone. It should not be used in type 1 diabetes or during episodes of diabetic ketoacidosis, and regular kidney function monitoring is recommended before treatment. Physicians stress that dosing must be individualized and never adjusted without medical advice.

Drug Class

• SGLT2 inhibitor and biguanide combination
• Antidiabetic, oral hypoglycemic agent

Empaa-M Tablet 12.5/500 formula

• Empagliflozin 12.5mg + Metformin Hydrochloride 500mg

Available forms

• Tablet

How to use Empaa-M Tablet 12.5/500?

• Take Empaa-M Tablet 12.5/500 exactly as prescribed by your doctor, usually once daily in the morning
• Swallow the tablet whole with a glass of water, with or without food
• Take it at the same time every day to maintain steady blood sugar control
• Do not crush, chew, or split the tablet unless your doctor advises otherwise
• Continue following your prescribed diet and exercise plan alongside this medicine
• Do not skip doses, and never double the dose to make up for a missed one
• Keep taking it regularly even if you feel well, since diabetes needs ongoing management

Drug Interactions

• Insulin And Sulfonylureas: Using these together with Empaa-M increases the risk of low blood sugar, so dose adjustments may be needed.
• Diuretics: Water pills can add to the dehydration risk from empagliflozin and may worsen kidney function.
• Iodinated Contrast Dye: Contrast dye used in imaging tests can affect kidney function and raise the risk of lactic acidosis when combined with metformin.
• Alcohol: Heavy alcohol use increases the risk of lactic acidosis and low blood sugar with this medicine.
• Corticosteroids: Steroid medicines can raise blood sugar levels and reduce how well Empaa-M controls glucose.
• ACE Inhibitors Or ARBs: These blood pressure medicines can affect kidney function and may need closer monitoring when taken with this medicine.

Risks and warnings

• Lactic Acidosis: Metformin carries a rare but serious risk of lactic acidosis, especially in people with kidney or liver problems, so seek urgent care if you notice unusual muscle pain, breathing difficulty, or extreme tiredness.
• Diabetic Ketoacidosis: Empagliflozin has been linked to a rare risk of ketoacidosis even when blood sugar levels appear normal, so report nausea, vomiting, or abdominal pain to your doctor right away.
• Dehydration And Low Blood Pressure: This medicine increases urination and fluid loss, which can cause dehydration or dizziness, particularly in hot weather or during illness.
• Genital And Urinary Infections: Empagliflozin raises the risk of yeast infections and urinary tract infections due to increased sugar in the urine, so maintain good hygiene and report symptoms early.
• Kidney Function: Both ingredients depend on healthy kidney function, so your doctor will check kidney tests before starting treatment and periodically afterward.
• Low Blood Sugar: The risk of hypoglycemia increases when this medicine is combined with insulin or sulfonylureas, so monitor for shakiness, sweating, or confusion.
• Surgery Or Contrast Dye Procedures: This medicine may need to be paused temporarily before surgery or procedures involving iodinated contrast dye, so inform your doctor about any planned tests.

Empaa-M Tablet 12.5/500 Side Effects

• Nausea or upset stomach
• Diarrhea
• Gas or bloating
• Loss of appetite
• Increased urination
• Genital yeast infections
• Urinary tract infections
• Mild dizziness
• Metallic taste in the mouth
• Signs of lactic acidosis such as severe muscle pain or trouble breathing
• Signs of ketoacidosis such as persistent nausea and abdominal pain
• Severe dehydration or fainting
• Signs of a serious allergic reaction such as rash, swelling, or difficulty breathing

Storage Conditions

• Store below 30 degrees Celsius in a cool, dry place
• Keep the tablets in their original blister pack away from moisture and direct sunlight
• Keep out of reach of children
• Do not store in the bathroom or near the kitchen sink
• Discard any expired or unused tablets safely